Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis

An effective serum biomarker may improve cholangiocarcinoma (CCA) management. Periostin (PN) has been demonstrated to be associated with aggressive CCA. The current study evaluated PN in blood serum for its diagnostic and prognostic potential in patients with CCA. Sera of 68 patients with CCA were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Thuwajit, Chanitra, Thuwajit, Peti, Jamjantra, Pranisa, Pairojkul, Chawalit, Wongkham, Sopit, Bhudhisawasdi, Vajarabhongsa, Ono, Junya, Ohta, Shoichiro, Fujimoto, Kiminori, Izuhara, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494708/
https://www.ncbi.nlm.nih.gov/pubmed/28693214
http://dx.doi.org/10.3892/ol.2017.6250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494708/
https://www.ncbi.nlm.nih.gov/pubmed/28693214
http://dx.doi.org/10.3892/ol.2017.6250

Ejemplares similares